Cordella Pulmonary Artery Sensor System (CorPASS)
Endotronix, Inc. · Decision date Sep 25, 2026
What did the FDA decide?
The FDA record for P230040/S033 lists a 30-Day Notice for the Cordella Pulmonary Artery Sensor System (CorPASS) under product code MOM, decided OK30 on 2026-09-25. The stated reason is a process change affecting manufacturer, sterilizer, packager or supplier. The listed change is that acceptance criteria for the Interrogation Inspection method were updated. The record does not specify which acceptance criteria changed, their prior or new values, or what the inspection covers.
The S033 identifier places this as a supplement to PMA P230040 rather than a new approval of the whole system. The stated purpose is a manufacturing process change; the record does not present it as evidence of safety or clinical effectiveness, and it adds no indication, trial or performance detail. Because the statement is brief, the scope of the revision stays unknown beyond the field label.
FDA approval order statement
updated acceptance criteria to the Interrogation Inspection method
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 25, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P230040/S033
- Regulatory pathway
- PMA supplement
- Applicant
- Endotronix, Inc.
- Product code
- MOM
- Decision code
- OK30
- Decision date
- Sep 25, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, hemodynamic, implantable.
- Applicant
- Endotronix, Inc.
- Product code
- MOM
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P230040. Subsequent supplements may change the device or its indications.
FDA decision timeline
P230040 · Original PMA
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S033 received
Application receipt date recorded by FDA.
P230040/S033 · FDA decision
30-Day Notice
P230040/S034 · Related supplement
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S031 · Related supplement
Cordelia Pulmonary Artery Pressure Sensor System (CorPASS)
P230040/S035 · Related supplement
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S030 · Related supplement
Cordella Pulmonary Artery Sensor System
Timeline entries are records held by MedtechLedger for P230040. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P230040
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Endotronix, Inc. | PMA approval | Jun 20, 2024 | FDA | |
| Endotronix, Inc. | PMA supplement | Oct 14, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Oct 20, 2026 | FDA | |
Cordella Pulmonary Artery Sensor SystemP230040/S030 | Endotronix, Inc. | PMA supplement | Oct 29, 2026 | FDA |
Explore the linked device profile
Other records with product code MOM
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Sep 30, 2026 | FDA | |
CardioMEMS PA Sensor and Delivery SystemP100045/S093 | ABBOTT MEDICAL | PMA supplement | Sep 30, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Sep 11, 2026 | FDA | |
| ABBOTT MEDICAL | PMA approval | May 28, 2014 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Endotronix, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 1415 W. Diehl Rd., Suite 500w, Naperville, IL, 60563
Sources and methodology
- Original FDA record: P230040/S033
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



